• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Platform Launches to Help Eliminate Biases in Decentralized Trials

by HITC Staff 01/20/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Platform Launches to Help Clinical Raters Eliminate Biases in Decentralized Trials

What You Should Know:

– Obviohealth, a decentralized clinical trial platform, has launched a new AI-assisted clinical raters platform to eliminate biases from trials.

The platform Augmented ePRO (electronic patient-reported outcomes), has been designed to assist clinical raters to better score patient outcomes, without biases.

Why It Matters

As more trials take place virtually or decentralized, clinical researchers are at the mercy of the quality of the information provided by the trial participants/patients, who, let’s be honest, may not follow directions well. This is particularly challenging for decentralized clinical trials (DCTs) that involve a rating system, where the participants are required to follow a scale for reporting the spectrum of their symptom or whatever it is they are asked to report (ex. Do you feel like your cough is a 1 or an 8?) For these types of rating systems, which run on a scale from 1-10, or from good to bad, patients often rate their symptoms incorrectly. These trials are not as accurate as they could and should be; without a professional rater or system in place to verify the data inputted. 

New platform enables the capture and rating of more precise, real-time data for decentralized clinical trials

This health IT tool features an annotation option, which allows clinicians to detail why a rating was determined. These clinical notes can serve over time to program automatic ratings, which will lead to better clinical rating processes in the future. It enables patients involved in decentralized clinical trials (DCTs) to upload photos, audio, or video in real-time using a patient-centric app provided by ObvioHealth. Once the media is uploaded to the platform, each outcome is assessed and scored by a clinician and/or expert rater. By utilizing a media-focused platform, biases in clinical ratings can be eliminated exponentially.

“Both patients and expert clinical raters will benefit from this AI-assisted tech platform throughout the data collection and assessment processes,” said Ivan Jarry, co-founder and CEO of ObvioHealth. “But, with an eye towards the future, the annotation feature is especially useful,  allowing clinicians to easily capture nuances in patient ratings that can be used to train AI algorithms and lead to even better clinical rating processes in the future.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Decentralized Clinical Trials

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |